Editor’s be aware: This text has been up to date with further context from Heal.
Heal, a home-based main care and telehealth firm, is planning layoffs forward of a possible sale.
In line with WARN notices, Heal would lower 182 jobs in Los Angeles County and 60 positions in New York Metropolis. An organization spokesperson instructed MobiHealthNews the corporate is in lively discussions with potential consumers, and it is required to file notices in New York and California relating to potential upcoming layoffs.
In late October, Heal introduced it could develop with Cigna Medicare Benefit members in Georgia, Illinois, North Carolina and South Carolina. The startup most not too long ago raised $100 million from insurer Humana in 2020.
Heal’s layoffs mark the most recent in a spate of job cuts at digital well being corporations. Earlier this month, digital behavioral well being firm SonderMind laid off 15% of its workers, not lengthy after it introduced the acquisition of Complete Mind.
Different digital well being companies which have not too long ago made cuts embrace Headspace Well being, Komodo Well being and OneStudyTeam.
Quris, a software program firm that makes use of AI to foretell viable drug candidates, raised $9 million in seed funding, bringing its whole elevate to $37 million.
The spherical was led by SoftBank Imaginative and prescient Fund 2 with current institutional and personal traders, together with iAngels, Richter Group, Welltech Ventures and GlenRock Capital.
In January, Quris garnered $28 million in its preliminary seed-funding spherical.
The corporate makes use of its Bio-AI Medical Prediction Platform to check the security of medicine through its Sufferers-on-a-Chip system, which mixes evaluation from stem-cell tissues and AI to simulate an individual’s response to a drug.
The brand new funding will assist the corporate develop its group, advance its platform, construct trade collaborations and speed up its analysis.
“We consider the early forecasting functionality that Quris is creating brings actual potential impression to the worldwide pharmaceutical trade,” Yossi Cohen, director of Israel operations for SoftBank Funding Advisers, mentioned in a press release. “Harnessing the novel utility of AI, Dr. Bentwich and his group may save the big prices of medicine failing in medical trials, and in doing so create a enterprise in Israel of great financial worth.”
Boston-based PharmStars, a pharma-focused digital well being accelerator, introduced that it is accepting purposes for its fourth cohort.
The spring 2023 digital program will give attention to digital well being options from all over the world that deal with ladies’s well being circumstances, and circumstances the place ladies are disproportionately affected or have worse outcomes. PharmStars may even take into account digital improvements that deal with well being inequities for underserved populations and that promote equitable, inclusive healthcare.
Launched in 2021, PharmStars focuses on educating well being tech corporations and pharma about working collectively. It gives mentoring to digital well being startups seeking to have interaction with pharma and biotech corporations.
The deadline for purposes for the spring 2023 cohort is January 14.
